Calendar Cartesian Therapeutics, Inc.

Equities

RNAC

US8162123025

Market Closed - Nasdaq 21:00:00 26/04/2024 BST 5-day change 1st Jan Change
21.03 USD +0.62% Intraday chart for Cartesian Therapeutics, Inc. +17.42% +1.68%

Chart calendar Cartesian Therapeutics, Inc.

a500722c4b89b8f62d9a312a20c.GvA-G-102-Nx6ekA15DceqmEcH4pNvzoaVVqXYmH2RU.cqN5XIYi7IlC3bpTmf3kLsHQKQlCYJ6RMD4-bNnxhk1juXsotzexuxanvA~1ddb1407c94e36734cea4df637eb31c6

Upcoming events on Cartesian Therapeutics, Inc.

10/05/2024 18:45 American Society of Gene & Cell Therapy Meeting - Abstract Number: 241

Past events on Cartesian Therapeutics, Inc.

09/04/2024 20:00 Needham Healthcare Conference
27/03/2024 13:00 Extraordinary Shareholders Meeting
26/03/2024 15:00 H.C. Wainwright Cell Therapy Virtual Conference
13/03/2024 12:40 Leerink Partners Global Biopharma Conference
07/03/2024 12:00 Q4 2023 Earnings Release
17/08/2023 13:30 Q2 2023 Earnings Call
17/08/2023 12:00 Q2 2023 Earnings Release
16/06/2023 15:00 Annual General Meeting
30/05/2023 European Alliance of Associations for Rheumatology European Congress
04/05/2023 13:30 Q1 2023 Earnings Call
04/05/2023 12:30 Q1 2023 Earnings Release
21/03/2023 12:30 DISSOLVE I & II SEL-212 Phase 3 Trail Results Call
02/03/2023 13:30 Q4 2022 Earnings Call
01/03/2023 Q4 2022 Earnings Release
14/02/2023 13:00 SVB Securities Global Biopharma Conference
14/11/2022 18:35 Immunology & Neurology Day
03/11/2022 12:30 Q3 2022 Earnings Call
03/11/2022 12:00 Q3 2022 Earnings Release
11/10/2022 17:30 European Society of Gene and Cell Therapy Conference - OR06
30/09/2022 19:30 Jefferies Cell and Genetic Medicine Summit

Annual results

Fiscal PeriodDecember 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
0,00


26,0
10,6
145.32%

0,00

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-86,4
-14,3
-506.39%

-40,3

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-6,46


-239
-13,7
-1645.21%

-32,2

Net income
Million USD
Released
Forecast
Spread
-6,46


-220
-13,7
-1506.3%

-37,8

EPS
USD
Released
Forecast
Spread
0,00


-49,8
-0,60
-8200.01%

-1,62

Announcement Date23/01/2407/03/24-

Quarterly results

Fiscal PeriodDecember 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD
Released
Forecast
Spread

2,50


0,00


0,00


0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread

-6,00


-8,63


-9,00


-10,4


-12,3


-14,0

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread

-5,91


-6,29


-7,62


-8,46


-9,81


-10,9

Net income
Million USD
Released
Forecast
Spread

-5,91


-8,14


-8,31


-9,73


-11,7


-13,5

EPS
USD
Released
Forecast
Spread

-0,30


-0,35


-0,36


-0,42


-0,50


-0,57

Announcement Date------

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. RNAC Stock
  4. Calendar Cartesian Therapeutics, Inc.